FDA Approved: BRAFTOVI — Original Application (Array BioPharma Inc.)

View source ↗

Summary

FDA approved BRAFTOVI (encorafenib) under the original application (NDA210496) from Array BioPharma Inc., marking the drug's initial approval for BRAFV600-mutan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Malignant Melanoma

Drugs mentioned

• BRAFTOVI (ENCORAFENIB)

Snippet

ORIG AP for BRAFTOVI (ENCORAFENIB)